Rizvi Talat J H, Fatima Hassan
PMRC Research Centre, National Institute of Child Health, Karachi.
J Coll Physicians Surg Pak. 2003 Dec;13(12):688-90.
To compare the frequency of antihepatitis C virus (HCV) after single blood transfusion, multiple blood transfusion and in non-transfused obstetric cases.
A comparative descriptive study.
The Department of Obstetric and Gynaecology, Jinnah Postgraduate Medical Centre, during the period of one-year from January 2002 to December 2002.
Patients included in the study after single transfusion were 38, after multiple transfusion 39, and controls 120. History of patients regarding all the relevant information and clinical examination were recorded on a specially-designed and coded proforma. Anti-HCV was detected by Roche HCV EIA 2nd generation kit method in all cases and controls. Descriptive statistics and frequency of anti HCV in each group was calculated using SPSS version 10.
Frequency of anti-HCV among patients with single blood transfusion was 13.2% (5), with multiple transfusion was 15.4% (6) and 6.6% (8) in non-transfused subjects.
Anti-HCV frequency after one pint blood was almost same (13.2%) as after multiple transfusion (15.4%). This positively provided a firm argument for the necessity of a nationwide blood donor screening for anti-HCV by most sensitive immunoassay. Equally important was the need for clear cut indication for single blood transfusion.
比较单次输血、多次输血及未输血产科病例中抗丙型肝炎病毒(HCV)的出现频率。
一项比较性描述性研究。
2002年1月至2002年12月期间,真纳研究生医学中心妇产科。
纳入研究的单次输血患者38例,多次输血患者39例,对照组120例。通过专门设计并编码的表格记录患者所有相关信息的病史及临床检查情况。所有病例及对照均采用罗氏HCV EIA第二代试剂盒法检测抗HCV。使用SPSS 10版计算每组抗HCV的描述性统计数据及出现频率。
单次输血患者中抗HCV出现频率为13.2%(5例),多次输血患者中为15.4%(6例),未输血者中为6.6%(8例)。
一品脱血液输血后抗HCV出现频率(13.2%)与多次输血后(15.4%)几乎相同。这有力地证明了通过最灵敏的免疫测定法对全国献血者进行抗HCV筛查的必要性。同样重要的是,单次输血需要有明确的指征。